PCR researchers Dr Toby Phesse and Dr Helen Pearson chat to Ben about their research project investigating whether blocking certain signals in the body can stop prostate cancer from spreading to other parts of the body.
This episode, we meet Dr Anna Wilkins whose PCR project is looking at using AI to predict whether an individual's cancer will return. She chats to host Ben Monro-Davies about the project and being part of PCR.
Dr Claire Fletcher talks to host Ben Monro-Davies about her PCR-funded research looking at the link between obesity and prostate cancer.
Robin chats to host Ben Munro-Davies about his experiences of living with prostate cancer. From being diagnosed in 2015 to being on active surveillance to working with PCR as a patient representative.
In this episode, host Ben Monro-Davies is joined by Dr Kirsteen Campbell from the Beatson Institute in Glasgow. Kirsteen talks about her PCR research project exploring the role of MCL-1, a molecule found at high levels in people with advanced prostate cancer, what it could mean for prostate cancer patients in the future and why this funding from PCR was so critical.
Host Ben Munro-Davies catches up with Professor Colin Cooper, Chair of the PCR Scientific Committee, on the changes and progress which have happened in prostate cancer research and treatment over the past couple of decades, the pitfalls of PSA screening, and why we still need good ideas.
PCR patient representative, Neal chats to host Ben Munro-Davies about his experiences since receiving a diagnosis of advanced prostate cancer in 2018. From navigating side effects from treatment to working with PCR to build a future in which no family will have to fear losing a loved one to prostate cancer.
This episode, we meet Dan Brewer and Dan Woodcock, for a chat about how artificial intelligence is a new frontier against prostate cancer.
PCR Chairman Matt Ellis outlines why PCR exists, how we navigated the pandemic, and why bringing a large range of different partners together to make progress against prostate cancer is a win-win for everybody.
PCR scientist Dr Magali Williamson, Kings College London, talks to host Ben Munro-Davies about why she first became interested in a gene called Plexin B1, which controls how cells move, and how she hopes to use what she's learned about this gene to stop prostate cancer spreading.
PCR scientist Professor Iain McEwan of the University of Aberdeen joins host Ben Munro-Davies for a chat about the androgen receptor, testosterone's gatekeeper, and his work to attack its Achilles' heel, so that hormone therapy can keep working.
David and Catherine Matheson have prostate cancer. One has it in his body, the other has it in her life. Tune in for a candid discussion on David’s diagnosis, how they chose his treatment, how they’ve continued to live their lives and why scientists sometimes need to be reminded that patients are human beings.
CellCentric's CEO, Dr Will West, chats to host Ben Munro-Davies about the exciting field of epigenetics, clinical trials, the world of biotech and their journey so far from lab to clinic.
"When does a dancer stop?" The legendary Sir Matthew Bourne, hailed as the UK's most popular and successful choreographer, chats to host Ben Munro-Davies about prostate cancer, his regular check-ups, and the world of dance.
Fighting Prostate Cancer takes many forms. But Chris Warwick and Rob Mepham have embarked on a unique challenge - driving a fleet of Austin Maestros across Britain to raise money for Prostate Cancer Research. They explain why this unsurprisingly forgotten car is perfect on the road representation of a disease that impacts millions.
